SAB Biotherapeutics SABS
NASDAQ SABS
$3.11 +0.04 (+1.30%)
At close: Nov 11, 2026 · 4:00 PM EST

SAB Biotherapeutics (SABS) Other Non-Current Assets (2020 - 2026)

Updated

SAB Biotherapeutics' Other Non-Current Assets came in at $13.1 million for Q4 2021, compared with $235,111 a year earlier.

Analysis

SAB Biotherapeutics (SABS) Other Non-Current Assets (2020 - 2026) Analysis & Trends

  • Going back by year, Other Non-Current Assets was $235,111 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 15.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.42 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 700.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.90 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.02 Bn
10 SAB Biotherapeutics 279.79 Mn -130.87 Mn - 5.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.81 Mn
Jun 30, 2026 5.34 Mn
Mar 31, 2026 5.28 Mn
Dec 31, 2025 5.31 Mn
Sep 30, 2025 124.07 Mn
Jun 30, 2025 156.38 Mn
Mar 31, 2025 188,689.00
Dec 31, 2024 220,997.00
Sep 30, 2024 253,305.00
Jun 30, 2024 285,613.00
Mar 31, 2024 317,922.00
Dec 31, 2023 350,230.00
Sep 30, 2023 371,191.00
Jun 30, 2023 434,000.00
Mar 31, 2023 434,000.00
Dec 31, 2022 467,694.00
Sep 30, 2022 501,388.00
Jun 30, 2022 535,082.00
Dec 31, 2021 13.10 Mn
Dec 31, 2020 235,111.00
API Access

SAB Biotherapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=SABS&period=max&api_key=YOUR_API_KEY